Last update 21 Nov 2024

AZD-2836

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Hepatitis C virus NS 5 protein x RNA polymerase
Mechanism
Hepatitis C virus NS 5 protein inhibitors, RNA polymerase inhibitors
Therapeutic Areas
Infectious DiseasesDigestive System Disorders
Active Indication-
Inactive Indication
Hepatitis CHepatitis C, Chronic
Originator Organization
AstraZeneca PLCAstraZeneca PLC
Active Organization-
Inactive Organization
AstraZeneca Pharmaceuticals Co. Ltd.AstraZeneca Pharmaceuticals Co. Ltd.AstraZeneca PLCAstraZeneca PLCArrow Therapeutics Ltd.Arrow Therapeutics Ltd.
+ [1]
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC24H20N6O2
InChIKeyUPPWMBQIDFTBEQ-UHFFFAOYSA-N
CAS Registry944278-62-0

Related

2
Clinical Trials associated with AZD-2836
EUCTR2007-000328-42-GB / Not yet recruitingNot Applicable
A clinical pharmacology study to determine the pharmacokinetic , safety and tolerability profile and antiviral activity of multiple oral doses of A-831 in otherwise healthy male Hepatitis C carriers with compensated liver disease. - Clinical pharmacology study of A-831 in Hepatitis C carriers
NCT00522808 / TerminatedPhase 1/2
A Clinical Pharmacology Study to Determine the Pharmacokinetic , Safety and Tolerability Profile and Antiviral Activity of Multiple Oral Doses of A-831 in Otherwise Healthy Male Hepatitis C Carriers With Compensated Liver Disease
100 Clinical Results associated with AZD-2836
Login to view more data
100 Translational Medicine associated with AZD-2836
Login to view more data
100 Patents (Medical) associated with AZD-2836
Login to view more data
100 Deals associated with AZD-2836
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis C, ChronicPhase 2
NZ
Arrow Therapeutics Ltd.Arrow Therapeutics Ltd.
01 Aug 2007
Hepatitis C, ChronicPhase 2
GB
Arrow Therapeutics Ltd.Arrow Therapeutics Ltd.
01 Aug 2007
Hepatitis CPhase 2-
AstraZeneca Pharmaceuticals Co. Ltd.AstraZeneca Pharmaceuticals Co. Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free